CJC-1295 is designed to stimulate GH release for a prolonged time, as it has a long half-life
Response: We thank commenters for their comments on this subject
Yesif its appropriate for your health needs
Ludwig MQ, Belmont-Rausch DM, Bentsen MA, Secher A, Hansen SAN, Egerod KL, et al
However, some mild side effects may occur, especially during the adjustment period or at higher doses: Headaches Temporary injection site irritation Lightheadedness Water retention (in rare cases) Mild tingling or numbness (from elevated IGF-1) Ipamorelin induced growth hormone release without elevating cortisol or ACTH levels, suggesting minimal off-target effects. Raun et al., European Journal of Endocrinology Compared to Other Peptides Unlike GHRP6 , which often causes intense hunger and spikes in prolactin , or GHRP2 , which can increase cortisol , Ipamorelin is more targeted and stable
Such devices, once validated, could guide therapy: for instance, if the probe shows high tissue oxygen but poor utilization (indicative of mitochondrial dysfunction), the team might intensify mitochondrial support interventions (208)